Connect MM Registry as a national reference for United States multiple myeloma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Connect MM Registry as a national reference for United States multiple myeloma patients

Published:2019-11-07 Issue:1 Volume:9 Page:35-42
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Ailawadhi Sikander¹^ORCID,Jagannath Sundar²,Narang Mohit³,Rifkin Robert M.⁴,Terebelo Howard R.⁵,Toomey Kathleen⁶,Durie Brian G. M.⁷,Hardin James W.⁸,Gasparetto Cristina J.⁹,Wagner Lynne¹⁰^ORCID,Omel James L.¹¹,Kumar Vivek¹²^ORCID,Yue Lihua¹³,Kitali Amani¹³,Agarwal Amit¹³,Abonour Rafat¹⁴,

Affiliation:

1. Mayo Clinic Jacksonville FL USA

2. Mount Sinai Hospital New York NY USA

3. US Oncology Research Columbia MD USA

4. Rocky Mountain Cancer Centers US Oncology Denver CO USA

5. Providence Cancer Institute Southfield MI USA

6. Steeplechase Cancer Center Somerville NJ USA

7. Cedars‐Sinai Medical Center Los Angeles CA USA

8. University of South Carolina Columbia SC USA

9. Duke University Medical Center Durham NC USA

10. Wake Forest School of Medicine Winston‐Salem NC USA

11. Myeloma Research Advocate/Advisor Grand Island NE USA

12. Brigham and Women's Hospital Boston MA USA

13. Celgene Corporation Summit NJ USA

14. Indiana University Indianapolis IN USA

Funder

Celgene

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2656

Reference25 articles.

1. Temporal trends in survival and healthcare costs in patients with multiple myeloma in the United States;Maiese EM;Am Health Drug Benefits,2018

2. Trends in overall survival and costs of multiple myeloma, 2000–2014

3. Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

4. High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma

5. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Age and Other Patient Characteristics on Outcomes Among Nontransplanted Patients Who Were Treated With First-Line Lenalidomide, Bortezomib, and Dexamethasone: Results From the ConnectⓇ MM Registry;Clinical Lymphoma Myeloma and Leukemia;2024-06

2. Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups;Blood Advances;2024-01-09

3. Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry;Practical Radiation Oncology;2023-11

4. Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients;Targeted Oncology;2023-09

5. Global disparities in patients with multiple myeloma: a rapid evidence assessment;Blood Cancer Journal;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3